Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "Ahmedabad"

195 News Found

Zydus gets USFDA’s approval for Empagliflozin, Metformin Hydrochloride tablets
Drug Approval | July 12, 2022

Zydus gets USFDA’s approval for Empagliflozin, Metformin Hydrochloride tablets

Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.


Biolexis and Akston Biosciences announce encouraging results of thermostable 2nd Gen COVID-19 vaccine
News | June 24, 2022

Biolexis and Akston Biosciences announce encouraging results of thermostable 2nd Gen COVID-19 vaccine

An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.


Zydus Lifesciences receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
Drug Approval | June 07, 2022

Zydus Lifesciences receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel

The drug will be manufactured at the group’s topical facility at Ahmedabad


Torrent Pharma acquires four brands from Dr Reddy’s
News | May 27, 2022

Torrent Pharma acquires four brands from Dr Reddy’s

The integration and transition of the brands are expected to be completed by June 2022.


Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
Drug Approval | May 24, 2022

Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol

Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.


Premas Biotech appoints Saumen Chakraborty to its Board
People | May 09, 2022

Premas Biotech appoints Saumen Chakraborty to its Board

Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad


Zydus receives tentative approval from USFDA for Selexipag tablets
Drug Approval | May 06, 2022

Zydus receives tentative approval from USFDA for Selexipag tablets

The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad


Fear of fourth wave drives Indians to search Covid health services
News | May 05, 2022

Fear of fourth wave drives Indians to search Covid health services

Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%


Glamyo Health records ARR of US $ 8 million last fiscal
Startup | April 25, 2022

Glamyo Health records ARR of US $ 8 million last fiscal

It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation